Financials

  • Market Capitalization 15.37 M
  • Employee 18
  • Founded 2017
  • CEO N/A
  • Website vyometx.com
  • Headquarter Delaware, United States
  • FIGI BBG0036S6JY0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.71
Rapporto prezzo/fatturato
23.26

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4688
KTTA
Pasithea Therapeutics Corp. - Common Stock
0.49 USD0.00%-2.00%-15.52%-28.99%16.37 M USD
4696
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.71 USD-4.38%+9.76%+12.08%+14.15%16.07 M USD
4704
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.34 USD0.00%0.00%-10.53%-73.85%16.52 M USD
4714
LEXX
Lexaria Bioscience Corp. - Common Stock
0.59 USD0.00%+11.32%-1.67%-29.76%14.62 M USD